Global Smart Inhalers Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2026

Global Smart Inhalers Market 2020 Industry Outlook, Comprehensive Insights, Growth and Forecast 2026


The global smart inhalers market size is set to gain impetus from the rising utilization of digital technology in the field of healthcare devices. It is aiding in increasing the efficiency of drug delivery devices and is, in turn, speeding up the treatment procedures. This information is published by Fortune Business Insights™ in a recent report, titled, “Smart Inhalers Market Size, Share & Industry Analysis, By Product (Dry Powder Inhaler (DPI) - Based Smart Inhalers, Metered Dose Inhaler (MDI) - Based Smart Inhalers), By Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel) and Regional Forecast, 2020-2027.” The report further mentions that the smart inhalers market size was USD 28.62 million in 2019 and is projected to reach USD 445.40 million by 2027, exhibiting a CAGR of 41.1% during the forecast period.


Please visit: https://www.fortunebusinessinsights.com/smart-inhalers-market-102705

 

Detailed Table of Content:

 

1.       Introduction

1.1.     Research Scope

1.2.     Market Segmentation

1.3.     Research Methodology

1.4.     Definitions and Assumptions

2.       Executive Summary

3.       Market Dynamics

3.1.     Market Drivers

3.2.     Market Restraints

3.3.     Market Opportunities

4.       Key Insights

4.1 Recent Industry Developments Such as Mergers & Acquisitions

4.2 Regulatory Scenario for Key Countries

4.3 Technological Advancements Pertaining to Smart Inhalers

4.4 Industry Background Pertaining to Smart Inhalers

4.5 Key Industry Trends

4.6 New Product Launch

5.       Global Smart Inhalers Market Analysis, Insights and Forecast, 2016-2027

5.1.     Key Findings / Summary

5.2.     Market Analysis, Insights and Forecast – By Product

5.2.1 Dry Powder Inhaler (DPI)- based Inhalers

5.2.2 Metered Dose Inhaler (MDI)- based Inhalers

5.3.     Market Analysis, Insights and Forecast – By Disease indication

5.3.1 Asthma

5.3.2 Chronic Obstructive Pulmonary Disease (COPD)

5.4.     Market Analysis, Insights and Forecast – By Distribution Channel

5.4.1 Hospital Pharmacies

5.4.2 Retail Pharmacies

5.4.3 Online Channel

5.5.     Market Analysis, Insights and Forecast – By Region

5.5.1 North America

5.5.2 Europe

5.5.3 Asia Pacific

5.5.4 Rest of the World (RoW)

6.       North America Smart Inhalers Market Analysis, Insights and Forecast, 2016-2027

6.1.     Key Findings / Summary

6.2.     Market Analysis, Insights and Forecast – By Product

6.2.1 Dry Powder Inhaler (DPI)- based Inhalers

6.2.2 Metered Dose Inhaler (MDI)- based Inhalers

6.3.     Market Analysis, Insights and Forecast – By Disease indication

6.3.1 Asthma

6.3.2 Chronic Obstructive Pulmonary Disease (COPD)

6.4.     Market Analysis, Insights and Forecast – By Distribution Channel

6.4.1 Hospital Pharmacies

6.4.2 Retail Pharmacies

6.4.3 Online Channel

6.5.     Market Analysis, Insights and Forecast -  By Country

6.5.1 U.S.

6.5.2 Canada

7.       Europe Smart Inhalers Market Analysis, Insights and Forecast, 2016-2027

7.1.     Key Findings / Summary

7.2.     Market Analysis, Insights and Forecast – By Product

7.2.1 Dry Powder Inhaler (DPI)- based Inhalers

7.2.2 Metered Dose Inhaler (MDI)- based Inhalers

7.3.     Market Analysis, Insights and Forecast – By Disease indication

7.3.1 Asthma

7.3.2 Chronic Obstructive Pulmonary Disease (COPD)

7.4.     Market Analysis, Insights and Forecast – By Distribution Channel

7.4.1 Hospital Pharmacies

7.4.2 Retail Pharmacies

7.4.3 Online Channel

7.5.     Market Analysis, Insights and Forecast -  By Country/Sub Region

7.5.1 U.K.

7.5.2 Germany

7.5.3 France

7.5.4 Spain

7.5.5 Italy

7.5.6 Rest of Europe

8.       Asia Pacific Smart Inhalers Market Analysis, Insights and Forecast, 2016-2027

8.1.     Key Findings / Summary

8.2.     Market Analysis, Insights and Forecast – By Product

8.2.1 Dry Powder Inhaler (DPI)- based Inhalers

8.2.2 Metered Dose Inhaler (MDI)- based Inhalers

8.3.     Market Analysis, Insights and Forecast – By Disease indication

8.3.1 Asthma

8.3.2 Chronic Obstructive Pulmonary Disease (COPD)

8.4.     Market Analysis, Insights and Forecast – By Distribution Channel

8.4.1 Hospital Pharmacies

8.4.2 Retail Pharmacies

8.4.3 Online Channel

8.5.     Market Analysis, Insights and Forecast -  By Country/Sub Region

8.5.1 Japan

8.5.2 China

8.5.3 India

8.5.4 Australia

8.5.5 Rest of Asia Pacific

9.       Rest of the World (RoW) Smart Inhalers Market Analysis, Insights and Forecast, 2016-2027

9.1.     Key Findings / Summary

9.2.     Market Analysis, Insights and Forecast – By Product

9.2.1 Dry Powder Inhaler (DPI)- based Inhalers

9.2.2 Metered Dose Inhaler (MDI)- based Inhalers

9.3.     Market Analysis, Insights and Forecast – By Disease indication

9.3.1 Asthma

9.3.2 Chronic Obstructive Pulmonary Disease (COPD)

9.4.     Market Analysis, Insights and Forecast – By Distribution Channel

9.4.1 Hospital Pharmacies

9.4.2 Retail Pharmacies

9.4.3 Online Channel

10.   Competitive Analysis

10.1.     Key Industry Developments

10.2.     Global Market Share Analysis (2019)

10.3.     Competition Dashboard

10.4.     Comparative Analysis – Major Players

10.5.     Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))

10.5.1 Adherium

10.5.2 Propeller Health

10.5.3 Cohero Health Inc.

10.5.4 GlaxoSmithKline

10.5.5 AstraZeneca plc

10.5.6 Novartis AG

10.5.7 3M Company

10.5.8 Teva Pharmaceuticals

10.5.9 Vectura Group

10.5.10 Others

Continued...



Report Page